All News

The proposed bill would force pharmacy benefit managers to act on the interests of pharmacies rather than their own companies.

Controlling symptoms of allergy and asthma helps patients improve quality of life.

From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.

Results of Eli Lilly’s investigational triple agonist were reported in the TRIUMPH-1 Phase 3 clinical trial.

New FDA guidance sharpens postmarket pregnancy drug safety data, improving labels and empowering pharmacists to report adverse events.

Although currently contained outside of the US, the Bundibugyo strain of the virus reached an American worker in the Democratic Republic of Congo.

New OASIS 4 data show early oral semaglutide responders hit 21.6% weight loss and improve mobility.

In this episode, Natalie DiPietro Mager, PharmD, PhD, meets with Sarah Chew, MPH, to discuss the pharmacist’s role in advancing women’s health research.

In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.

Declining Black-owned pharmacies reshape community care, and pharmacists can advance health equity today.

The announcement comes with a partnership with Mark Cuban Cost Plus Drug Company, Amazon Pharmacy, and GoodRx.

With Commissioner Makary resigning just days prior, this marks the second and third major change in the federal agency’s leadership this month.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, provided his expert perspectives on the ongoing hantavirus outbreak.

Between clinical initiatives, educational strategies, and regulatory frameworks, researchers explore PGx services integration.

From PBM reform designed to benefit pharmacies to closures impacting the greater public health sector, Tom DePietro, PharmD, discusses current developments in community pharmacy.

The approval also includes an interchangeability designation, meaning both products can be substituted at the pharmacy level.

FDA approves Baxfendy, a new oral aldosterone blocker, to help hard-to-control hypertension.

Despite a myriad of data and news releases about the growing prominence of AI in pharmacy practice, several knowledge and acceptance gaps persist.

Black pharmacists help to power civil rights, voter drives, and community care, linking history to today’s fight for health equity.

Black pharmacists help to fuel civil rights—through drugstores, voter drives, and health equity—offering lessons for today’s care gaps.

An exploration of key takeaways from the first 4 episodes of Scripted for Her, featuring host Natalie DiPietro Mager, PharmD, PhD, and experts from a variety of clinical backgrounds in women’s health.

Oral ensitrelvir given within 72 hours cuts household symptomatic COVID-19 by 67%, showing safe postexposure prevention.

As diabetes rises to be one of the most prominent chronic diseases globally, pharmacists have reached out as key resources for preventing and managing its complications.

Meta-analysis shows empagliflozin is superior to sitagliptin with metformin for glycemic control.

HHS targets SSRI overuse, urging pharmacists and clinicians to reassess long-term therapy, use safer tapers, and expand nondrug care.

As health officials respond to ongoing concerns, Nathan Ott, PharmD, joined to discuss key hantavirus facts that pharmacists can relay to their communities.

Among both childhood and adult populations, researchers assess the quality of life across a large cohort of patients reporting pneumococcal disease cases.

Mapping data reveals where pharmacy access collapses and how policymakers can fight medication deserts.